BCSCDB: Biomarkers of Cancer Stem Cells Database
Number of entries related to HCC827 cell line is 54
| GENE | HGNC_ID | MARKER_TYPE | CANCER_TYPE | HISTOLOGICAL_TYPE | CELL_LINE | CSC_ENRICHMENT | METHOD | EXPRESSION_LEVEL | CONFIDENCE_SCORING | GLOBAL_SCORING | PUBMED_ID |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CD44 | 1681 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | HCC827 | NA | FACs followed by IHC staining and SFA | NA | 0.36 | 1 | 21124918 |
| CD44 | 1681 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | HCC827 | NA | FACs followed by SFA and Tumorigenicity assay | NA | 0.36 | 1 | 24091605 |
| CD44 | 1681 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | HCC827 | NA | FACs followed by SFA and Tumorigenicity assay | NA | 0.36 | 1 | 28819374 |
| CD44 | 1681 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | HCC827 | NA | SFA followed by FACs | NA | 0.36 | 1 | 25965829 |
| POU5F1 | 9221 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | HCC827 | NA | FACs followed by IF staining | NA | 0.36 | 0.6448 | 21124918 |
| POU5F1 | 9221 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | HCC827 | NA | FACs followed by SFA and qPCR | NA | 0.36 | 0.6448 | 24091605 |
| POU5F1 | 9221 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | HCC827 | NA | SFA followed by Western Blotting | NA | 0.36 | 0.6448 | 33955683 |
| POU5F1 | 9221 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | HCC827 | NA | SFA followed by Western Blotting | NA | 0.36 | 0.6448 | 30305725 |
| POU5F1 | 9221 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | HCC827 | Gefitinib | qRT-PCR | NA | 0.36 | 0.6448 | 33764690 |
| POU5F1 | 9221 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | HCC827 | Gefitinib | qPCR | NA | 0.36 | 0.6448 | 24489728 |
| POU5F1 | 9221 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | HCC827 | NA | SFA followed by RT-PCR | NA | 0.36 | 0.6448 | 28787001 |
| POU5F1 | 9221 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | HCC827 | Gefitinib | SP assay followed by qRT-PCR and CFA | NA | 0.36 | 0.6448 | 25871388 |
| NANOG | 20857 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | HCC827 | NA | FACs followed by SFA and qPCR | NA | 0.32 | 0.5461 | 24091605 |
| NANOG | 20857 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | HCC827 | NA | SFA followed by Western Blotting | NA | 0.32 | 0.5461 | 30305725 |
| NANOG | 20857 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | HCC827 | Gefitinib | qRT-PCR | NA | 0.32 | 0.5461 | 33764690 |
| NANOG | 20857 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | HCC827 | Gefitinib | qPCR | NA | 0.32 | 0.5461 | 24489728 |
| NANOG | 20857 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | HCC827 | NA | SFA followed by RT-PCR | NA | 0.32 | 0.5461 | 28787001 |
| NANOG | 20857 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | HCC827 | Gefitinib | SP assay followed by qRT-PCR and CFA | NA | 0.32 | 0.5461 | 25871388 |
| SOX2 | 11195 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | HCC827 | NA | FACs followed by SFA and qPCR | NA | 0.32 | 0.5695 | 24091605 |
| SOX2 | 11195 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | HCC827 | NA | SFA followed by Western Blotting | NA | 0.32 | 0.5695 | 33955683 |
| SOX2 | 11195 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | HCC827 | NA | SFA followed by Western Blotting | NA | 0.32 | 0.5695 | 30305725 |
| SOX2 | 11195 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | HCC827 | Gefitinib | qPCR | NA | 0.32 | 0.5695 | 24489728 |
| ABCB1 | 40 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | HCC827 | Afatinib | Western Blotting and CFA | NA | 0.28 | 0.0604 | 26202045 |
| ABCB1 | 40 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | HCC827 | Docetaxel | RT-PCR | NA | 0.28 | 0.0604 | 28959367 |
| ALDH1A1 | 402 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | HCC827 | NA | SFA followed by Western Blotting | NA | 0.28 | 0.684 | 33955683 |
| ALDH1A1 | 402 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | HCC827 | Afatinib | Western Blotting and CFA | NA | 0.28 | 0.684 | 26202045 |
| ALDH1A1 | 402 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | HCC827 | Erlotinib | ALDEFLUOR assay followed by FACs and SFA | NA | 0.28 | 0.684 | 25125655 |
| ALDH1A1 | 402 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | HCC827 | Gefitinib | qRT-PCR | NA | 0.28 | 0.684 | 33764690 |
| ALDH1A1 | 402 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | HCC827 | Gefitinib | qPCR | NA | 0.28 | 0.684 | 24489728 |
| ALDH1A1 | 402 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | HCC827 | Docetaxel | RT-PCR | NA | 0.28 | 0.684 | 28959367 |
| ALDH1A1 | 402 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | HCC827 | NA | SFA followed by RT-PCR | NA | 0.28 | 0.684 | 28787001 |
| ALDH1A1 | 402 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | HCC827 | Gefitinib | SP assay followed by qRT-PCR and CFA | NA | 0.28 | 0.684 | 25871388 |
| ALDH1A1 | 402 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | HCC827 | Gefitinib | ALDEFLUOR assay and SFA | NA | 0.28 | 0.684 | 31765940 |
| ALDH1A1 | 402 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | HCC827 | NA | ALDEFLUOR assay followed by CFA | NA | 0.28 | 0.684 | 24907115 |
| ALDH1A1 | 402 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | HCC827 | NA | FACs followed by SFA and Tumorigenicity assay | NA | 0.28 | 0.684 | 24091605 |
| ALDH1A1 | 402 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | HCC827 | NA | FACs followed by SFA and Tumorigenicity assay | NA | 0.28 | 0.684 | 28819374 |
| IL8 | 6025 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | HCC827 | NA | SFA followed by Western Blotting | NA | 0.28 | 0.0159 | 30305725 |
| IL8 | 6025 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | HCC827 | NA | SFA followed by Western Blotting | NA | 0.28 | 0.0159 | 30305725 |
| PRDX2 | 9353 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | HCC827 | Gefitinib | Western Blotting | NA | 0.28 | 0.0074 | 30341415 |
| PROM1 | 9454 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | HCC827 | NA | SFA followed by Western Blotting | NA | 0.28 | 0.7582 | 33955683 |
| PROM1 | 9454 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | HCC827 | Gefitinib | Western Blotting | NA | 0.28 | 0.7582 | 30341415 |
| PROM1 | 9454 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | HCC827 | Gefitinib | qRT-PCR | NA | 0.28 | 0.7582 | 33764690 |
| PROM1 | 9454 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | HCC827 | Gefitinib | qPCR | NA | 0.28 | 0.7582 | 24489728 |
| PROM1 | 9454 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | HCC827 | NA | SFA followed by RT-PCR | NA | 0.28 | 0.7582 | 28787001 |
| PROM1 | 9454 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | HCC827 | NA | SFA followed by FACs | NA | 0.28 | 0.7582 | 25965829 |
| SLC2A3 | 11007 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | HCC827 | NA | SFA followed by Western Blotting | NA | 0.28 | 0.0042 | 30305725 |
| BMI1 | 1066 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | HCC827 | Gefitinib | SP assay followed by qRT-PCR and CFA | NA | 0.2 | 0.1135 | 25871388 |
| BMI1 | 1066 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | HCC827 | NA | FACs | NA | 0.2 | 0.1135 | 21124918 |
| CXCR4 | 2561 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | HCC827 | Gefitinib | qRT-PCR | NA | 0.2 | 0.0498 | 33764690 |
| CXCR4 | 2561 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | HCC827 | Gefitinib | qPCR | NA | 0.2 | 0.0498 | 24489728 |
| NDRG1 | 7679 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | HCC827 | NA | SFA followed by RT-PCR and Tumorigenicity assay | NA | 0.2 | 0.0064 | 28456659 |
| NES | 7756 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | HCC827 | Gefitinib | SP assay followed by qRT-PCR and CFA | NA | 0.2 | 0.0573 | 25871388 |
| ZEB1 | 11642 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | HCC827 | Gefitinib | qRT-PCR | NA | 0.2 | 0.0074 | 33764690 |
| CD34 | 1662 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | HCC827 | NA | FACs | NA | 0.12 | 0.0053 | 21124918 |